Volume 28, Issue 128 (May & June 2020)                   J Adv Med Biomed Res 2020, 28(128): 151-155 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hosseini S, Yousefi M, Ebrahimi M. Effect of Different Doses of Vitamin A on β-HCG Production in Patients Suffering from Gestational Trophoblastic Disease. J Adv Med Biomed Res 2020; 28 (128) :151-155
URL: http://journal.zums.ac.ir/article-1-5903-en.html
Effect of Different Doses of Vitamin A on β-HCG Production in Patients Suffering from Gestational Trophoblastic Disease
Shokoufeh Hosseini1 , Masoumeh Yousefi2 , Maryam Ebrahimi * 3
1- Dept. of Statistics, Faculty of Mathematical Sciences, Alzahra University, Tehran, Iran
2- Dept. of Midwifery and Reproductive Health, Iran University of Medical Sciences, Tehran, Iran
3- Dept. of Obstetrics and Gynecology, Akbarabadi Hospital, Iran University of Medical of Sciences, Tehran, Iran , Drmkhoddami@yahoo.com
Abstract:   (145958 Views)

Background and Objective: Gestational trophoblastic disease (GTD) is a type of disease which is characterized by increased production of B-HCG by placental cells. Increased β-HCG production is due to increased proliferation of beta cells and lack of apoptosis. If left untreated, it can lead to malignancy. Almost 30-50 of GTD progresses to gestational trophoblastic neoplasia (GTN) in women over 40 years old. This study aimed to evaluate the effect of vitamin A doses (100,000 IU and 200,000 IU) on the decrement of β-HCG levels.
Materials and Methods: The study included three groups: two patients and one control, and each group contained 22 individuals. Two groups of patients (A and B) received 100,000 IU and 200,000 IU doses of vitamin A, respectively, in addition to suction curettage. β-HCG levels were then measured by radioimmunoassay (RIA).
Results: The β-HCG drop-in group B, which received 200,000 IU of vitamin A, was higher than that of group A. It was significant in the third and fourth weeks after the treatment compared to the control group. There was also a significant relationship between the three groups in terms of Gravid (P<0.001). All the patients were followed up for 6 months.
Conclusion: Considering that in the long run, the dose of 200,000 IU compared to the dose of 100,000 IU of vitamin A did not significantly reduce the B-HCG, therefore, in order to prevent the complications of high doses, the single dose of 100,000 IU was used for GTD patients.

Keywords: Gestational trophoblastic disease (GTD), β-HCG, Gravid, Parity, Vitamin A
Full-Text [PDF 341 kb]   (155073 Downloads) |   |   Full-Text (HTML)  (3194 Views)  

✅ Considering that in the long run, the dose of 200,000 IU compared to the dose of 100,000 IU of vitamin A did not significantly reduce the B-HCG, therefore, in order to prevent the complications of high doses, the single dose of 100,000 IU was used for GTD patients.


Type of Study: Original Article | Subject: Clinical medicine
Received: 2020/01/15 | Accepted: 2020/03/14 | Published: 2020/05/1
References
1. Shaaban AM, Rezvani M, Haroun RR, et al. Gestational trophoblastic disease: clinical and imaging features. Radiographics. 2017;37(2):681-700. [DOI:10.1148/rg.2017160140]
2. Ngan HY, Seckl MJ, Berkowitz RS, et al. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynecol Obstet. 2015;131:S123-S6. [DOI:10.1016/j.ijgo.2015.06.008]
3. Usui H, Qu J, Sato A, et al. Gestational trophoblastic neoplasia from genetically confirmed hydatidiform moles: prospective observational cohort study. Int J Gynecol Cancer. 2018;28(9):1772-80. [DOI:10.1097/IGC.0000000000001374]
4. Niemann I, Vejerslev LO, Frøding L , et al. Gestational trophoblastic diseases-clinical guidelines for diagnosis, treatment, follow-up, and counselling. Dan Med J. 2015;62(11):A5082.
5. Lertkhachonsuk A, Hanvoravongchai P. Comparison of cost-effectiveness between actinomycin D versus methotrexate-folinic acid in the treatment of low-risk gestational trophoblastic neoplasia. J Rep Med. 2016;61(5-6):230-4.
6. Braga A, Maestá I, Matos M, Elias KM, Rizzo J, Viggiano MGC. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation. Gynecol Oncol. 2015;139(2):283-7. [DOI:10.1016/j.ygyno.2015.09.012]
7. Verit FF. May platelet count be a predictor of low-risk persistent gestational trophoblastic disease? Arch Gynecol Obstet. 2011;283(4):695-9. [DOI:10.1007/s00404-010-1408-2]
8. Whitworth JM, Straughn JM, Atigadda VR, Muccio DD, Buchsbaum DJ. The use of retinoids in ovarian cancer: a review of the literature. Int J Gynecol Cancer. 2012;22(2):191-8. [DOI:10.1097/IGC.0b013e318236a2ec]
9. Sun P, Wu Q, Ruan G, et al. Expression patterns of maspin and mutant p53 are associated with the development of gestational trophoblastic neoplasia. Oncol Lett. 2016;12(5):3135-42. [DOI:10.3892/ol.2016.5074]
10. Zadeh FJ, Janatmakan F, Soltanzadeh M, Zamankhani M. Investigating the effect of fibrinogen injection on bleeding in coronary artery bypass surgery: A clinical trial. Anesthesiol Pain Med. 2019;9(4): e92165 [DOI:10.5812/aapm.92165]
11. Wu M, Zhang H, Hu J, et al. Isoalantolactone inhibits UM-SCC-10A cell growth via cell cycle arrest and apoptosis induction. PloS one. 2013;8(9). [DOI:10.1371/journal.pone.0076000]
12. Kolusari A, Kurdoglu M, Yildizhan R, et al. Catalase activity, serum trace element and heavy metal concentrations, and vitamin A, D and E levels in pre-eclampsia. J Int Med Res. 2008;36(6):1335-41. [DOI:10.1177/147323000803600622]
13. Al Riyami N, Al Riyami M, Al Thuriya Al Hajri SA, Saidi BS, Al Kalbani M. Gestational trophoblastic disease at Sultan Qaboos University Hospital: Prevalence, risk factors, histological features, sonographic findings, and outcomes. Oman Med J. 2019;34(3):200. [DOI:10.5001/omj.2019.39]
14. Andrijono A, Muhilal M. Prevention of post-mole malignant trophoblastic disease with vitamin A. Asian Pac J Cancer Prev. 2010;11(2):567-70.
15. Zadeh FJ, Moadeli M, Soltanzadeh M, Janatmakan F. Effect of remote ischemic preconditioning on troponin I in CABG. Anesthesiol Pain Med. 2017;7(4). [DOI:10.5812/aapm.12549]
16. Cunningham FG, Leveno K, Bloom S, Hauth J, Gilstrap L, Wenstrom K. Gestational trophoblastic disease. Williams Obstetrics 22nd ed New York: McGraw Hill. 2005.
17. Stevens F, Katzorke N, Tempfer C, et al. Gestational trophoblastic disorders: an update in 2015. Geburtshilfe Frauenheilkunde. 2015;75(10):1043-50. [DOI:10.1055/s-0035-1558054]
18. Feizollahi N, Zayeri ZD, Moradi N, Zargar M, Rezaeeyan H. The effect of coagulation factors polymorphisms on abortion. Front Biol. 2018;13(3):190-6. [DOI:10.1007/s11515-018-1500-8]
19. Mazul AL, Weinberg CR, Engel SM, et al. Neuroblastoma in relation to joint effects of vitamin A and maternal and offspring variants in vitamin A-related genes: A report of the Children's Oncology Group. Cancer Epidemiol. 2019;61:165-71. [DOI:10.1016/j.canep.2019.06.009]
20. Berkowitz RS, Cramer DW, Bernstein MR, Cassells S, Driscoll SG, Goldstein DP. Risk factors for complete molar pregnancy from a case-control study. AmJ Obstet Gynecol. 1985;152(8):1016-20. [DOI:10.1016/0002-9378(85)90550-2]
21. Lawler S, Pickthall V, Fisher R, Povey S, Evans MW, Szulman A. Genetic studies of complete and partial hydatidiform moles. The Lancet. 1979;314(8142):580. [DOI:10.1016/S0140-6736(79)91632-5]
22. Kolusari A, Adali E, Kurdoglu M, Yildizhan R, Cebi A, Edirne T, et al. Catalase activity, serum trace element and heavy metal concentrations, vitamin A, vitamin D and vitamin E levels in hydatidiform mole-Serum levels of catalase, Zn, Co, and vitamin A, D, and E were significantly lower in patients with hydatiform mole compared with healthy pregnant women and non pregnant controls. Clin Experiment Obstet Gynecol. 2009;36(2):102. [DOI:10.1177/147323000803600622]
23. Bakhtiyari M, Mirzamoradi M, Kimyaiee P, Aghaie A, Mansournia MA, Ashrafi-vand S, et al. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors. Fertil Steril. 2015;104(3):649-54. [DOI:10.1016/j.fertnstert.2015.06.001]
24. Ghasemian S, Yousefi Z, Farazestanian M, Seresht LM, Foroughipour M, Akhlaghi S. Effect of combination therapy of methotrexate with vitamin A in patients with low risk GTN (Gestational Trophoblastic Neoplasia). IranJ Pharmaceut Res. 2018;17(Suppl):38.
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb